Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: Results of a gynecologic oncology group study-Reference-Cited by-同舟云学术

Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: Results of a gynecologic oncology group study

Published:1996-01 Issue:1 Volume:34 Page:139-147
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Randall Marcus E.,Barrett Rolland J.,Spirtos Nick M.,Chalas Eva,Homesley Howard D.,Lentz Samuel L.,Hanna Mark

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Collateral resistance to photon and neutron irradiation is associated with acquired cis-platinum resistance in human ovarian tumor cells;Britten;Radiother. Oncol.,1992

2. Regression models and lifetables;Cox;J. Royal Stat. Soc.,1972

3. Epithelial ovarian cancer: The role of radiotherapy;Dembo;Int. J. Radiat. Oncol. Biol. Phys.,1992

4. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma;Eifel;Int. J. Radiat. Oncol. Biol. Phys.,1991

5. Correlation between response to cisplatin-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck;Ensley;Cancer,1984

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study;Gynecologic Oncology;2019-07

2. Ovary;Clinical Radiation Oncology;2017-05-05

3. Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study;Gynecologic Oncology;2016-12

4. Ovarian Cancer;Clinical Radiation Oncology;2016

5. Neoplastic Diseases of the Ovary;Comprehensive Gynecology;2013